CAR T-Cell Therapy Access Remains Elusive, But Solutions May Be Closer Than Expected
September 9th 2023Widespread access to CAR T-cell therapy remains a problem, and quite a few challenges have arisen in regards to optimizing outcomes for CAR T-cell therapy in patients with hematologic malignancies and solid tumors.